Mass Torts - Fluoroquinolone

Mass Torts - Fluoroquinolone

Introduction

Following up on our last month's newsletter about drugs causing more harm than good, there apparently is another drug that fits that mold namely Fluoroquinolones. A variety of illnesses such as urinary tract infections and respiratory are treated by this group of antibiotics. There are some well-known Fluoroquinolones on the market, such as Levaquin, Avelox, Noroxin, among others. However, the FDA strengthened its warning regarding Fluoroquinolones as they may cause sudden, severe, and possibly permanent nerve damage, also known as peripheral neuropathy (nerve damage).

Moreover, Neural IT is able to prepare Chronologies & Medical Summaries involving records of patients treated for injuries caused by Fluoroquinolones. Also, we provide bookmarking and tagging of medical records.

For Fluoroquinolone, Neural IT is also well-equipped to help firms with Plaintiff fact sheets.

Quinolone antibiotic, belonging to a large group of broad-spectrum bacteriocides, from the general two-ring structure, the most important thing is to carry out in case the issue is a 4-quinolone. They are also used by the people of the veterinary medicinal products for the treatment of bacterial infections, as well as in animal husbandry.

It can be said that all of the quinolone antibiotics are fluoroquinolones, which contain the fluorine atom in their chemical structure and are effective against both gram-negative bacteria and gram-positive bacteria. Such as ciprofloxacin, is one of the most widely used antibiotics in the world.

For community-acquired infections, fluoroquinolones are recommended if there are risk factors for many of the drug resistance, or that of any antibiotic treatment regimens, which have become ineffective. However, in the most serious acute cases of pyelonephritis or bacterial prostatitis, as a person may be in a hospital, fluoroquinolones are recommended as first-line therapy.

As a person with sickle cell anemia are at increased risk for osteomyelitis from the Salmonella, fluoroquinolones are the "drugs of choice" because of its ability to penetrate into the bone, the skin and tissue without chelating, as is well known, this is the tetracyclines. Fluoroquinolones, to occupy a prominent place in the treatment of hospital-acquired pneumonia.

In most countries, the use of fluoroquinolones in children is not only limited and, in some cases, the monitoring of the high incidence of musculoskeletal adverse reactions in young animals that have been treated with fluoroquinolones. In the UK, the prescription of fluoroquinolones for children are severely restricted. Only the inhalation of anthrax and pseudomonal infections in cystic fibrosis, is a licensed indications in the UK due to ongoing safety concerns. In a study comparing the safety and efficacy of levofloxacin with azithromycin or ceftriaxone in 712 children with community-acquired pneumonia, serious adverse reactions were observed in 6% of those who received levofloxacin and 4% of those who received the comparison of antibiotics. Most of them are, in the opinion of the attending physician, is not related to or are suspected of being related to the study drug. Two of the follow-up to death in the levofloxacin group, neither of them were-and treatment-related. Approximately 130,000 children, prescriptions for levofloxacin were filled on behalf of 112,000 children's patients during this time period.

A meta-analysis has shown that fluoroquinolones pose virtually no risk to the baby.